Since Angptl8 is a lipid metabolism-associated hormone that is released mainly from liver and adipose tissue, our study provides the possibility that HFD-induced downregulation of GNMT may increase the production and release of Angptl8, leading to the increase of plasma triglyceride levels in metabolic syndrome. The gene discussed is GNMT; the disease is metabolic syndrome.